Pathogenic mechanisms in familial amyotrophic lateral sclerosis due to mutation of Cu, Zn superoxide dismutase.
Oxidative mechanisms of damage have been implicated indirectly in the damage to brain tissue caused acutely by ischemia or chronically by neurodegenerative diseases. A direct link between pathogenesis and antioxidant enzyme systems has come from studies of a genetic form of amyotrophic lateral sclerosis (ALS). ALS causes the degeneration of motor neurons in cortex, brainstem and spinal cord with consequent progressive paralysis and death. The disease occurs in both sporadic and familial forms. Some 20% of kindreds in which ALS is inherited in an autosomal dominant fashion have mutations in the gene (SOD1) encoding Cu, Zn superoxide dismutase (SOD). Several SOD1 mutations have been shown by ourselves and others to cause motor neuron disease when expressed at high levels in transgenic mice, whereas transgenic mice expressing comparable amounts of wild-type human SOD do not show clinical disease. Thus, we have argued that motor neuron disease is caused by gain-of-function mutations in the human SOD1 gene. Our current experiments investigate the link between mutation of SOD1 and oxidative pathways of damage.
Gurney
M E
ME
Central Nervous System Diseases Research Unit, Upjohn Laboratories, Kalamazoo, MI 49001, USA.
Cutting
F B
FB
Zhai
P
P
Andrus
P K
PK
Hall
E D
ED
D000690:Amyotrophic Lateral Sclerosis / Q000235:genetics* / Q000517:prevention & control; D000818:Animals; D002869:Chromosome Aberrations / Q000235:genetics*; D025063:Chromosome Disorders; D002891:Chromosomes, Human, Pair 21; D018691:Excitatory Amino Acid Antagonists; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D009154:Mutation; D019782:Riluzole; D013482:Superoxide Dismutase / Q000235:genetics*; D013844:Thiazoles / Q000627:therapeutic use; D014810:Vitamin E / Q000627:therapeutic use
D018691:Excitatory Amino Acid Antagonists; D013844:Thiazoles; D014810:Vitamin E; D019782:Riluzole; D013482:Superoxide Dismutase